Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study 著者: Frank Buttgereit, Dorothy McCabe, Eun Bong Lee, Vibeke Strand, Abraham Simon-Campos, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi

全文の入手

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical tria... 著者: Carsten Flohr, Michael J. Cork, Michael R. Ardern-Jones, Lawrence F. Eichenfield, Sébastien Barbarot, Claire Feeney, Ricardo Rojo, Irina Lazariciu, John Nesnas

全文の入手

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life 著者: Andrew Blauvelt, Mark Boguniewicz, Patrick M. Brunner, Paula C. Luna, Pinaki Biswas, Marco DiBonaventura, Saleem A. Farooqui, Ricardo Rojo, Michael C. Cameron

全文の入手

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: resul... 著者: Kaiyin Fei, Peter C Taylor, Tom WJ Huizinga, Georg Schett, Matthew J Loza, Chetan S Karyekar, Bei Zhou, Jocelyn H Leu, Qingmin Wang, Keying Ma, Fowzia Ibrahim, Yuan Xiong, Sheng Gao, Sophia G Liva, Jafar Sadik B Shaik, Rohit A Panchakshari, Harman Dhatt, Ricardo Rojo Cella, Carolyn A Cuff

全文の入手